Scientific Director/Sr. Director/Executive Director - Process Chemistry - Oligonucleotides at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • Extensive knowledge of oligonucleotide development
  • Fluent knowledge in modern synthetic organic and nucleic acid chemistry methods
  • Experience in chemistry, manufacturing, and control (CMC) of oligonucleotides
  • High learning agility with ability to understand and exploit new scientific concepts and methods across multiple disciplines
  • Strong skills related to automated reactor platforms and purification technologies
  • Examples of novel contributions to chemical design and mechanism-based problem solving (e.g., total synthesis, novel methodology development, oligonucleotide synthesis), reflected in a strong publication record in peer-reviewed journals
  • Solid understanding in unit operation design, process modeling, process equipment selection, and scale-up methodologies

Responsibilities

  • Grow internal capabilities through coaching, mentorship, and leadership
  • Challenge existing methods, define new manufacturing technologies, and apply them to deliver portfolio and address key CMC challenges
  • Lead a cross-disciplinary team to evaluate and refine manufacturing routes, technologies, and practices to deliver LGM portfolio
  • Apply learnings to portfolio of small molecules, oligonucleotides, synthetic peptides, and other emerging synthetic modalities
  • Build and apply groundbreaking technology and novel platforms within a time-constrained environment
  • Provide technical leadership in scale-up and demonstration of new chemical processes in development and commercial scale equipment
  • Collaborate with internal (Lilly Medicine Foundry) and external CMOs on oligonucleotide synthesis, tech transfer, and campaign execution
  • Lead CMC activities to support clinical trials, product commercialization, and regulatory submissions of oligonucleotide therapeutics
  • Support development and optimization of methods, exploration of novel synthetic approaches to oligonucleotides and conjugates, plus purification, isolation, and formulation

Skills

Key technologies and capabilities for this role

Process ChemistryOligonucleotidesCMCSynthetic ChemistryDrug Substance DevelopmentDrug Product DevelopmentPurificationFormulationRegulatory SubmissionsClinical TrialsManufacturingGenetic Medicines

Questions & Answers

Common questions about this position

What is the salary for this Scientific Director position?

This information is not specified in the job description.

Is this role remote or does it require working from a specific location?

This information is not specified in the job description.

What key skills are required for this oligonucleotide process chemistry role?

Candidates need extensive knowledge of oligonucleotide development, fluent knowledge in modern synthetic organic and nucleic acid chemistry methods, high learning agility across disciplines, and strong skills in automated reactor platforms and purification technologies.

What is the company culture like at Eli Lilly?

Eli Lilly unites caring with discovery to make life better for people, puts people first, and emphasizes giving best effort to work while contributing to communities through philanthropy and volunteerism.

What makes a strong candidate for this position?

Top candidates bring extensive oligonucleotide development expertise, lead cross-disciplinary teams, coach and mentor to grow internal capabilities, and drive innovation in manufacturing technologies for the LGM portfolio.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI